Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Not yet recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Colonic Neoplasms 2

Interventions

Oxaliplatin 6tislelizumab 3Irinotecan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3sintilimab 2raltitrexed 2pembrolizumab 2Surgical Procedures, Operative 2Specimen Handling 2Neoadjuvant Therapy 2Laparoscopy 2HMPL-013 2spartalizumab 1rimegepant sulfate 1encorafenib 1cemiplimab 1balstilimab 1XELOX 1Surgical Fixation Devices 1Radiofrequency Ablation 1Propranolol 1Preoperative Exercise 1Pemetrexed 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mortality 1Magnetic Resonance Spectroscopy 1Leucovorin 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Colonic Neoplasms × raltitrexed × Clear all
NCT06665087 2024-10-30

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

Fudan University

Phase 2 Not yet recruiting
110 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT06652412 2024-10-28

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

Fudan University

Phase 2 Not yet recruiting
124 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡